Cholesterol is an essential lipid component of membranes and is a precursor of a wide range of signalling molecules. Disturbed cholesterol homeostasis is predominantly associated with the development of cardiovascular disease, but it is now well-recognized that this also plays a critical role in, amongst others, metabolic-associated fatty liver disease (MASLD) and its transition to hepatocellular carcinoma, cancer in general, and neurodegenerative diseases (e.g. Niemann-Pick disease and Alzheimer’s Disease). Our group is interested in elucidating the molecular regulation of lipid metabolism, and in this ZonMW funded project you will focus on the role of the lysosome in cholesterol handling, and specifically on cholesterol trafficking from this organelle.
The lysosome is an essential cholesterol-trafficking hub, as is clearly illustrated in lysosomal cholesterol diseases such as Niemann-Pick disease (NPC). Cholesterol exit from the lysosome is tightly coordinated, but the molecular determinants involved are not fully known. In this PhD project, you will use genetic screens, CRISPR/Cas9-mediated genome-editing, proximity proteomics, cell-based functional assays, and advanced metabolic mouse models to identify and study novel mechanisms that govern lysosomal cholesterol handling. Our goal is to elucidate control of lysosomal cholesterol egress, so as to understand how this contributes to disease development when proper control is lost.
For this 4 year PhD position in the research group of Prof. Noam Zelcer we are looking for an enthusiastic candidate that meets the following requirements:
Watch this video with more information about joining Amsterdam UMC Research BV.
This 4 year ZonMW funded PhD position will be supervised by Prof. Noam Zelcer. This project is a close collaboration with Prof. Bart van de Sluis and Dr. Karin Wolters (UMC Groningen, The Netherlands), who also have a PhD position available. The Zelcer lab aims to elucidate the molecular regulation of lipid metabolism using a combination of cellular and experimental mouse models, and harnesses this knowledge to diagnose and treat cardiometabolic diseases, such as non-alcoholic fatty liver disease and atherosclerosis, and rare inherited lipid disorders like NPC and X-ALD. The Zelcer group is an international and dymanic research group that is embedded in the Department of Medical Biochemsitry of the Amsterdam UMC. More information about the group and our recent work can be found on Zelcer lab website.
Amsterdam UMC Research BV supports non-profit scientific research. In doing so, we provide researchers with everything they need to excel. Our principal investigators (PIs) and project leaders offer support in the field of project management, finance and human resources. In medical scientific research projects, legal support is also provided.
Watch the video to find out more.
Note: Applications should include a CV, cover letter, and the contact information of at least two references. An assessment may be part of the selection procedure. The first interview will be conducted online, and will be followed by a second on-site interview.
During the publication period, applications will be handled continuously. You will receive a reply from us regarding your application no later than May 23rd, 2025.
If you have any questions about this position, please feel free to contact Prof. Noam Zelcer via n.zelcer@amserdamumc.nl.
For more information about the application procedure, please contact Rhiannon Sandfort, Recruitment advisor, via r.e.sandfort@amsterdamumc.nl.
Internal candidates will be given priority over external candidates in case of equal suitability.
Acquisition in response to this vacancy is not appreciated.